Abstract

Ouedraogo SM, Sangaré I, Sourabié Y, Zongo R , Zida A Ouedraogo AS, Fofana S , Guiguemdé RT

: The interaction of these two pathologies raises capital issues as well as therapeutic. This study aims at a better understanding of the clinical, biological and therapeutic profile of HIV-malaria coinfected children. Methodology: It is a prospective and retrospective cross-sectional study. Were involved patients infected with HIV followed in the department whose clinical and laboratory diagnosis of malaria had been made and / or patients with whom the diagnosis of coinfection was made through a medical consultation. Results: The prevalence of coinfection was 3.09%. The clinical signs of severity were dominated by impaired consciousness and seizures. As for biological signs, anemia was found with 65% of patients and thrombocytopenia with 9.3% of cases. Immunocompetent patients accounted for 70.7% of coinfected patients. Pharmaco therapeutic groups which were administered were hyperleucocytoses, they were found with 19.6% of coinfected patients mainly antimalarials (100% of cases), analgesics-antipyretics (79.6% of cases) and ARV(48.1% of cases). Conclusion: Immunosuppression caused by HIV infection did not appear to be associated with the frequency of occurrence of malaria. Chemo malaria prophylaxis with HIV positive children is not necessary.